A duo of medical and legal experts from Brown and Harvard Universities argues that if the U.S. decides to consider the practice, it has a well-drawn regulatory roadmap to follow
Brown University researchers may have discovered what’s responsible for discrepant findings between dozens of fundamental studies of the biology of aging.
Researchers behind the study hope that the discovery can be used to develop better treatment against influenza and chronic inflammation conditions such as rheumatoid arthritis.